Cutaneous leishmaniasis is regulated by Wnt antagonist Dkk-1 from activated platelets (MPF7P.715)
Bothwell A, Chae W, Ehrlich A, Teixeira A, Goldsmith-Pestana K, Maher S, Hwa J, Krause D, McMahon-Pratt D. Cutaneous leishmaniasis is regulated by Wnt antagonist Dkk-1 from activated platelets (MPF7P.715). The Journal Of Immunology 2015, 194: 203.16-203.16. DOI: 10.4049/jimmunol.194.supp.203.16.Peer-Reviewed Original ResearchNeutrophil-platelet aggregate formationDkk-1Cutaneous leishmaniasisLate inflammatory responseSkin inflammatory diseasesT cell differentiationMajor infectionAntigen exposureLymph nodesChronic inflammationTh2 cytokinesInflammatory diseasesInflammatory responseTh2 cellsSkin lesionsSmall molecule inhibitorsParasite burdenGATA-3Functional inhibitionMarked inhibitionLeishmaniasisC-MafHuman plateletsMolecule inhibitorsPlateletsRegulation of chronic lung inflammation to house dust mite allergen by Wnt antagonist (CAM1P.144)
Bothwell A, Chae W, Teixeira A, Chan P, Hao L, Rothlin C, Krause D. Regulation of chronic lung inflammation to house dust mite allergen by Wnt antagonist (CAM1P.144). The Journal Of Immunology 2015, 194: 48.1-48.1. DOI: 10.4049/jimmunol.194.supp.48.1.Peer-Reviewed Original ResearchLeukocyte-platelet aggregatesCD4 T cellsAllergen challengeDkk-1D miceWildtype miceT cellsType 2 immune responsesHouse dust mite allergenWnt antagonistsLigand 1 expressionMediastinal lymph nodesType 2 cytokinesChronic lung inflammationInfiltration of leukocytesDust mite allergenAirway inflammationAllergen exposureLung inflammationLymph nodesLeukocyte infiltrationTh2 cellsCell adhesion moleculeImmune responseICAM-1